Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Pierre Fabre
Welcome,
Profile
Billing
Logout
26 Products
211 Diseases
26 Products
193 Trials
10550 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
18
36
54
72
90
108
126
144
162
180
Mektovi
(binimetinib) / Pfizer
Braftovi
(encorafenib) / Pfizer
Nerlynx
(neratinib) / Puma
Navelbine oral
(vinorelbine tartrate oral) / Pierre Fabre
Savella
(milnacipran) / AbbVie, Pierre Fabre
Javlor
(vinflunine) / Pierre Fabre
Gemtesa
(vibegron) / Merck (MSD)
dalotuzumab
(MK 0646) / Merck (MSD), Pierre Fabre
Fetzima
(levomilnacipran ER) / Pierre Fabre, AbbVie
Condrosulf
(chondroitin sulfate) / IBSA Institute Biochemical SA, Pierre Fabre
Tab-cel
(tabelecleucel) / Pierre Fabre
TriptoSar
(omtriptolide) / Pierre Fabre
befiradol
(NLX-112) / Neurolixis
recombinant ectodysplasin A1
(APO200) / Valerio Therap, Pierre Fabre
exarafenib
(KIN-2787) / Pierre Fabre
ibuprofen lozenges
(V-0498) / Pierre Fabre
F17464
/ Pierre Fabre
PFL-721
/ Pierre Fabre
V-0162
/ Pierre Fabre
telisotuzumab
(h224G11) / AbbVie
F14512
/ Pierre Fabre
F373280
/ Pierre Fabre
W0180
/ Pierre Fabre
lonigutamab
(VB421) / Pierre Fabre, Alumis
lonigutamab ugodotin
(W0101) / Pierre Fabre, Roche
